Related Experiment Videos
Heart rate variability in chronic heart failure
S Guzzetti1, R Magatelli, E Borroni
1Centro Ricerche Cardiovascolari, Università di Milano, Italy. stefanog@fisiopat.sacco.unimi.it
Insights
Heart rate variability (HRV) analysis reveals significant differences in chronic heart failure (CHF) patients, with reduced variance and low-frequency components indicating increased mortality risk. Further understanding is needed for clinical application in CHF prognosis and therapy.
Area of Science:
- Cardiology
- Autonomic Nervous System Function
- Heart Failure Research
Background:
- Heart rate variability (HRV) analysis offers insights into autonomic cardiovascular control.
- Numerous studies over 15 years highlight significant HRV differences between chronic heart failure (CHF) patients and healthy individuals.
Purpose of the Study:
- To review the prognostic capacity of HRV variables in CHF.
- To emphasize the need for understanding the physiopathological basis of HRV alterations in CHF for clinical utility.
Main Methods:
- Literature review of articles on HRV and CHF published in the last 15 years.
- Analysis of findings regarding HRV differences and prognostic capacity in CHF patients.
Main Results:
- HRV is significantly altered in CHF patients compared to controls.
- Reduced variance (SDNN) and low-frequency spectral components of HRV are associated with increased CHF mortality.
- These prognostic HRV variables are not yet integrated into routine clinical practice.
Conclusions:
- HRV analysis demonstrates significant prognostic value in CHF.
- Further research into the physiopathology of HRV changes in CHF is crucial.
- Understanding these mechanisms will enable the use of HRV for prognosis and personalized therapy in CHF patients.
Abstract:
The analysis of heart rate variability (HRV) provides information about autonomic cardiovascular control in healthy subjects. In the past 15 years, several articles have been published regarding HRV and chronic heart failure (CHF). The results of these papers substantially demonstrated that HRV is significantly different in CHF patients compared to controls. Moreover, some variables derived from HRV analysis showed significant independent prognostic capacity. In particular, the reduction of variance (expressed as SDNN) and low-frequency spectral component of HRV (ranging from 0.03 to 0.15 Hz) seem related to an increased mortality in CHF. Nevertheless, these variables are not yet considered in clinical practice. A better understanding of the physiopathological basis of the reported alterations of HRV in CHF patients is required in order to permit its use as a clinical tool for prognosis and tailored therapy in individual CHF patients.